O'Shaughnessy Asset Management, LLC Kamada LTD Transaction History

O'Shaughnessy Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.43 - $6.81 $81,308 - $101,972	-14,974 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$5.21 - $6.82 $46,999 - $61,523	-9,021 Reduced 37.6%	14,974 $99,000
Q3 2021 Nov 10, 2021	SELL	$5.25 - $5.87 $29,473 - $32,954	-5,614 Reduced 18.96%	23,995 $127,000
Q2 2021 Aug 09, 2021	BUY	$5.67 - $6.33 $167,883 - $187,424	29,609 New	29,609 $172,000
Q1 2021 May 14, 2021	SELL	$6.02 - $8.06 $373,998 - $500,735	-62,126 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$6.3 - $8.46 $149,725 - $201,060	-23,766 Reduced 27.67%	62,126 $403,000
Q3 2020 Nov 12, 2020	BUY	$8.02 - $11.73 $62,756 - $91,787	7,825 Added 10.02%	85,892 $718,000
Q2 2020 Aug 13, 2020	BUY	$5.37 - $9.45 $247,562 - $435,654	46,101 Added 144.22%	78,067 $606,000
Q1 2020 May 13, 2020	BUY	$4.56 - $7.13 $71,172 - $111,285	15,608 Added 95.42%	31,966 $186,000
Q4 2019 Feb 12, 2020	BUY	$4.97 - $7.7 $65,608 - $101,647	13,201 Added 418.15%	16,358 $112,000
Q3 2019 Nov 14, 2019	SELL	$5.11 - $5.99 $50,634 - $59,354	-9,909 Reduced 75.84%	3,157 $16,000
Q2 2019 Aug 07, 2019	BUY	$5.39 - $6.26 $70,425 - $81,793	13,066 New	13,066 $72,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $332M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.